AzTrials
AzTrials

Postpartum Depression (PPD)iCARENCT07384273

Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression

A study testing Internet-based therapy (iCARE) and treatment as usual and Treatment as usual (TAU) in people with Postpartum Depression (PPD), run by University of Southern Denmark at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Postpartum depression (PPD) is a common and serious condition affecting 9.5% of women in high-income countries, and around 8% in Denmark. It shares core features with major depression, including low mood, loss of interest, and impaired functioning. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Postpartum Depression (PPD)
What is being tested?
Internet-based therapy (iCARE) and treatment as usual and Treatment as usual (TAU)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
352 participants
Where
1 siteDenmark
Study dates
1 Feb 2026to 1 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Given birth within 6 months
  • Edinburgh Postnatal Depression Scale (EPDS) score above 7
  • ≥age 18
  • Access to the internet

Who cannot join

  • Do not understand Danish language,
  • Substance abuse or dependence
  • Alcohol abuse, defined by a weekly consumption of alcohol exceeding 10 units
  • A diagnosis of schizophrenia, other psychotic disorders or in immediate need of psychiatric treatment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Trine Munk-Olsen, PhD contact

+4524466297

tmun@sdu.dk

Denmark1 site, 1 recruiting
  • Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark

    Odense, 5250

    Trine Munk-Olsen, PhD, +4524466297, tmun@sdu.dk

    Recruiting

Other trials in Denmark

About this study

Postpartum depression (PPD) is a common and serious condition affecting 9.5% of women in high-income countries, and around 8% in Denmark. It shares core features with major depression, including low mood, loss of interest, and impaired functioning. Untreated PPD can persist for months, negatively impacting maternal well-being, child development, and family dynamics. In Denmark, systematic screening using the Edinburgh Postnatal Depression Scale (EPDS) is standard practice, but access to PPD treatment varies widely across municipalities.

Cognitive behavioral therapy (CBT) is the most effective psychological intervention for perinatal depression, yet limited availability and long wait times create barriers to access to care. Internet-based CBT (iCBT) offers a scalable, cost-effective alternative that can be delivered flexibly at home. Evidence supports the efficacy of self-guided iCBT for depression, though challenges such as high dropout rates have been reported. International trials in Norway, Portugal, Iran, South Korea, and the US have shown promising results for iCBT in perinatal populations. Some recent iCBT based interventions have also incorporated elements of Acceptance and Commitment Therapy (ACT) - which emphasizes psychological flexibility via mindfulness-based acceptance and values-driven action-and have demonstrated efficacy in reducing postpartum depression symptoms. These kinds of interventions (either iCBT or iCBT + ACT) have not yet been tested and evaluated in Denmark.

Read more

This clinical trial aims to evaluate whether adding an iCBT intervention with elements from ACT (iCARE) to treatment as usual (TAU) is more effective than TAU alone in reducing depressive symptoms in mothers with symptoms of PPD.

Moreover, a qualitative process evaluation of the iCARE will explore implementation, acceptability, and mechanisms of impact. Its primary aim is to understand how participants experience the iCARE intervention and TAU, focusing on implementation fidelity, acceptability, and contextual influences. The secondary aim is to explore perceived mechanisms of change (e.g., cognitive, emotional, behavioral) and barriers/facilitators to engagement.

Being tested
Internet-based therapy (iCARE) and treatment as usual, Treatment as usual (TAU)
Keywords
Postpartum depression, Cognitive behavioural therapy, Internet-based therapy, Acceptance and commitment therapy, Randomised controlled trial
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based therapy (iCARE) and treatment as usualBehavioural

    The iCARE program is a self-guided iCBT intervention that also incorporates selected exercises and approaches from ACT. The iCARE program consists of four core modules and four optional modules. Together, these exercises aim to enhance psychological flexibility, reduce negative thinking, and promote well-being in daily life.

    The core modules focus on self-care and mindfulness (Module 1), identifying and reframing unrealistic expectations with self-compassion (Module 2), increasing positive experiences and countering self-critical thoughts (Module 3), and recognizing and challenging thinking traps (Module 4). The additional optional modules provide strategies for practicing being present, communicating needs and asking for support, bonding with the baby, and coping with scary thoughts.

  • Treatment as usual (TAU)Other

    In Denmark, there is large variation in the available prevention and treatment municipalities offers for women experiencing symptoms of PPD. Some municipalities offer specialized psychological support and support groups, while others provide only basic follow-up by health nurses. Women can also be referred to their general practitioner, who can provide free ongoing follow-up and prescribe antidepressant medication if needed. Alternatively, it is possible to be referred to a privately practicing psychologist, usually with some out-of-pocket cost.

Study groups in NCT07384273
Study groupRoleWhat they receive
Internet-based therapy (iCARE) and treatment as usualExperimentalThe iCARE program is a self-guided iCBT intervention that also incorporates selected exercises and approaches from ACT. The iCARE program consists of four core modules and four optional modules. Together, these exercises aim to enhance psychological flexibility, reduce negative thinking, and promote well-being in daily life. The core modules focus on self-care and mindfulness (Module 1), identifying and reframing unrealistic expectations with self-compassion (Module 2), increasing positive experiences and countering self-critical thoughts (Module 3), and recognizing and challenging thinking traps (Module 4). The additional optional modules provide strategies for practicing being present, communicating needs and asking for support, bonding with the baby, and coping with scary thoughts.
Receives: Behavioral: Internet-based therapy (iCARE) and treatment as usual
Treatment as usualActive comparatorIn Denmark, there is large variation in the available prevention and treatment municipalities offers for women experiencing symptoms of PPD. Some municipalities offer specialized psychological support and support groups, while others provide only basic follow-up by health nurses. Women can also be referred to their general practitioner, who can provide free ongoing follow-up and prescribe antidepressant medication if needed. Alternatively, it is possible to be referred to a privately practicing psychologist, usually with some out-of-pocket cost.
Receives: Other: Treatment as usual (TAU)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms of postpartum depression

    The Edinburgh Postnatal Depression Scale (EPDS) is a validated screening questionnaire that measures symptoms of postnatal depression, such as low mood, anxiety, and loss of enjoyment, over the past week. It helps identify mothers who may need further assessment or support but does not provide a diagnosis. The primary outcome is the between-group difference in change from baseline to 2-month follow-up in EPDS score (range 0-30; higher scores indicate more severe symptoms). A clinically meaningful response is defined as a ≥3-point reduction from baseline. Participants will be categorized as responders/non-responders, and proportions will be reported for each group.

    Measured: Baseline At 2 months (primary endpoint) At 6 months (secondary endpoint)

Secondary outcomes (4)
  1. Symptoms of anxiety

    The Generalized Anxiety Disorder assessment (GAD-7) is a validated self-report questionnaire designed to assess symptoms of generalized anxiety disorder and overall anxiety severity. It consists of seven items scored from 0 (not at all) to 3 (nearly every day), producing a total score ranging from 0 to 21. Higher scores indicate greater anxiety symptoms. While the GAD-7 was originally developed to measure Generalized Anxiety Disorder, it has also been validated as a general measure of symptom severity of anxiety across different anxiety disorders in heterogeneous samples. In this trial, changes in GAD-7 scores from baseline to 2 and 6 months will indicate whether the intervention reduces anxiety symptoms.

    Measured: Baseline At 2 months (primary endpoint) At 6 months (secondary endpoint)

  2. Health-related disability and functioning

    World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic, internationally validated tool for assessing health-related disability and functioning. The 12-item version used here provides a total score from 0 (no disability) to 48 (severe disability). It captures the broader impact of mental health symptoms on daily functioning and quality of life. Changes from baseline to 2 and 6 months will help determine whether iCARE improves overall functioning beyond symptom reduction.

    Measured: Baseline At 2 months (primary endpoint) At 6 months (secondary endpoint)

  3. Automatic negative thoughts/negative self-statements

    The Automatic Thoughts Questionnaire (ATQ) measures the frequency of automatic negative thoughts (negative self-statements). The shortened 8 item version will be used. It includes 8 items rated on a 5-point Likert scale, assessing thoughts such as self-criticism, hopelessness, and personal failure. Scores range from 0 (few negative thoughts) to 32 (frequent negative thoughts). Evaluating between-group differences in ATQ at 2 months follow-up will indicate whether the intervention effectively targets maladaptive thinking patterns.

    Measured: At 2-months (primary endpoint)

  4. Parental Stress

    The Danish Parental Stress Scale (DPSS) measures stress related to parenting responsibilities. It consists of 18 items rated on a 5-point scale, with total scores ranging from 18 (low stress) to 90 (high stress). Assessing DPSS at 2 months will help determine whether the intervention reduces stress associated with caring for an infant.

    Measured: At 2-months (primary endpoint)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2026
  2. Study start1 Feb 2026
  3. Primary completion1 Aug 2028 (estimated)
  4. Study completion1 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Superiority, two-arm, randomised controlled trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
352 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07384273
Sponsor's protocol ID
16-0302-23
Other IDs
23/15327, 12.250, 514-1114/25-3000, 16-0302-23
Acronym
iCARE
Status last verified
Feb 2026
First submitted
21 Jan 2026
Last updated
5 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The individual de-identified participant data will be stored in (Open Patient data Explorative Network) and access might be available for affiliated researchers under data governance and approvals. The code will be available from the corresponding author on reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based therapy (iCARE) and treatment as usual and Treatment as usual (TAU) in people with Postpartum Depression (PPD), run by University of Southern Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Trine Munk-Olsen, PhD (+4524466297, tmun@sdu.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms of postpartum depression (time frame: Baseline At 2 months (primary endpoint) At 6 months (secondary endpoint)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in